SEBASTIANI GUIDO

Presentation

Guido Sebastiani is a Molecular Biologist and Associate Professor of Translational and Laboratory Medicine at the Department of Medical, Surgery and Neuroscience  (UNISI).

His main research interests are in Diabetes, metabolic and autoimmune diseases with special focus on RNA and non-coding RNA. To this end, Prof. Sebastiani has multiple National and International collaborations to his credit and is an active member of European consortia/projects (e.g. INNODIA, HEDIMED) that aim to identify extracellular RNAs as a source of new circulating biomarkers of chronic metabolic diseases and using multi-omics data analysis.

He is currently a Lecturer in Laboratory Medicine at the Master of Science Degree in Medicine and Surgery and at the School of Clinical Pathology and Clinical Biochemistry. "

Office hours

  • Monday from 09:00 to 11:00
    Place: Via Fiorentina,1- Edificio 36

Curriculum Vitae

Teaching activities

Completion accademic year: 2024/2025

Course year: 2 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2023/2024
Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2024/2025
Course year: 1 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2024/2025
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023

Completion accademic year: 2023/2024

Course year: 2 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2022/2023
Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2023/2024
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022

Completion accademic year: 2022/2023

Research

Ultime pubblicazioni:

  • Sassi, G., Licata, G., Ventriglia, G., Wouters, A., Lemaitre, P., Seurinck, R., et al. (2023). A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes. DIABETES, db220852 [10.2337/db22-0852]. - view more
  • Fignani, D., Pedace, E., Licata, G., Grieco, G.E., Aiello, E., de Luca, C., et al. (2023). Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors. DIABETES/METABOLISM RESEARCH AND REVIEWS, 39(8), 1-9 [10.1002/dmrr.3696]. - view more
  • Brusco, N., Sebastiani, G., Di Giuseppe, G., Licata, G., Grieco, G.E., Fignani, D., et al. (2023). Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes. DIABETOLOGIA [10.1007/s00125-022-05814-2]. - view more
  • Xiao, P., Takiishi, T., Violato, N.M., Licata, G., Dotta, F., Sebastiani, G., et al. (2022). NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes. CELL DEATH & DISEASE, 13(5), 1-11 [10.1038/s41419-022-04931-5]. - view more
  • Grieco, G.E., Brusco, N., Fignani, D., Nigi, L., Formichi, C., Licata, G., et al. (2022). Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation. CELL DEATH DISCOVERY, 8(1), 1-13 [10.1038/s41420-022-01142-x]. - view more